tm logo
PAPILLEX
Live/Registered
REGISTERED

on 07 Jun 2022

Last Applicant/ Owned by

115 George Street, Suite 218

Oakville, Ontario

CA

L6J0A2

Serial Number

90638639 filed on 12th Apr 2021

Registration Number

6750634 registered on 07th Jun 2022

in the Principal Register

Correspondent Address

Mary Catherine Merz

Mary Catherine Merz

408 MADISON STREET, SUITE A

OAK PARK, IL 60302

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

PAPILLEX

(Based on 44(e)) (Based on Use in Commerce) Nutraceuticals, namely, supplements for the treatment of HPV, namely, Human Papilloma Virus and associated conditions, specifically, genital warts and cervical dysplasia; (Based on Use in Commerce) Nutritional supplements containing herbs and nutrients that benefit the immune system

Classification Information


Class [005]
Pharmaceutical Products


(Based on 44(e)) (Based on Use in Commerce) Nutraceuticals, namely, supplements for the treatment of HPV, namely, Human Papilloma Virus and associated conditions, specifically, genital warts and cervical dysplasia; (Based on Use in Commerce) Nutritional supplements containing herbs and nutrients that benefit the immune system


First Use Date in General

30th Apr 2009

First Use Date in Commerce

30th Apr 2009

Mark Details


Serial Number

No 90638639

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 26039

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Jun 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Jun 2022REGISTERED-PRINCIPAL REGISTER
31st May 2022ASSIGNED TO EXAMINER
29th Apr 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
28th Apr 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
28th Mar 2022NOTICE OF ALLOWANCE CANCELLED
28th Mar 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
08th Mar 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11th Jan 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Jan 2022PUBLISHED FOR OPPOSITION